The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction

scientific article

The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/AHG.12046
P932PMC publication ID4013426
P698PubMed publication ID24359476
P5875ResearchGate publication ID259446512

P50authorToni-Kim ClarkeQ55763072
David OslinQ90363772
Helen Marie PettinatiQ109580310
P2093author name stringWade H Berrettini
Kyle M Kampman
Falk W Lohoff
Charles A Dackis
Amy R D Weiss
Charles P O'brien
Thomas N Ferarro
P2860cites workPLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
Distinct functions of the two isoforms of dopamine D2 receptorsQ28138415
Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learningQ28590865
Controlling the false discovery rate in behavior genetics researchQ29614833
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traitsQ29614876
Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performanceQ33533750
Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humansQ33711011
DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophreniaQ34508840
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.Q34574817
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuseQ34662050
Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addictionQ35661488
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.Q36300098
DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT bindingQ36471450
Prominence of the dopamine D2 short isoform in dopaminergic pathwaysQ36507451
Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interactionQ36593856
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.Q37092462
Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphismsQ37384257
Illicit use of methadone among i.v. drug users in MontrealQ39386888
Dopamine receptors: structure and function.Q40714663
Genetic association between dopamine transporter protein alleles and cocaine-induced paranoiaQ42280937
Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairsQ42642168
Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilitiesQ42686475
Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependenceQ43156338
Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patientsQ43268539
Potential association of DRD2 and DAT1 genetic variation with heroin dependenceQ43296088
Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ44634738
Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twinsQ44869447
Cocaine use, abuse and dependence in a population-based sample of female twinsQ45116057
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitutionQ46047802
Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han ChineseQ47792372
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusersQ48279855
Cocaine and heroin dependence compared in poly-drug abusersQ51772614
D2 receptor genotype and striatal dopamine signaling predict motor cortical activity and behavior in humans.Q53260429
Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patientsQ79464438
Resting posterior minus frontal EEG slow oscillations is associated with extraversion and DRD2 genotypeQ84285396
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectdopamineQ170304
opioidQ427523
P304page(s)33-39
P577publication date2013-11-25
P1433published inAnnals of Human GeneticsQ4767852
P1476titleThe dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction
P478volume78

Reverse relations

cites work (P2860)
Q38348213A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use
Q27312296A review of pharmacogenetic studies of substance-related disorders
Q46501122Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors
Q64777182DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum
Q33599626DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory
Q27003334Dopamine and glucose, obesity, and reward deficiency syndrome
Q47360280Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.
Q47843882Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial
Q34891066Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants
Q92617530Functional tag SNPs inside the DRD2 gene as a genetic risk factor for major depressive disorder in the Chinese Han population
Q94417368GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™): LESSONS LEARNED FROM AMERICA
Q35686543Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction
Q36767475Genetics and epigenetics of circadian rhythms and their potential roles in neuropsychiatric disorders
Q42367819Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112 117).
Q34304684Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.
Q33727978Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families.
Q36482731Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility
Q35684332Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction
Q47761163Neural and psychological characteristics of college students with alcoholic parents differ depending on current alcohol use.
Q35439069Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans
Q37223916Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients
Q54947826The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates.
Q43075979The genetic epidemiology of substance use disorder: A review
Q30277983The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations
Q42201173Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions